Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Bausch & Lomb (BLCO) Receivables - Other (2021 - 2023)

Bausch & Lomb posted quarterly Receivables - Other of $95.0 million for Q1 2023, up 17.28% year-on-year from $81.0 million in Q1 2022, and down 6.86% on a QoQ basis from $102.0 million in Q4 2022.

Bausch & Lomb (BLCO) has 3 years of Receivables - Other data on file, last reported at $95.0 million in Q1 2023.

  • For the quarter ending Q1 2023, Receivables - Other rose 17.28% year-over-year to $95.0 million; the trailing twelve-month figure through Mar 2023 stood at $95.0 million (up 17.28% YoY), and the FY2022 full-year result was $102.0 million, up 218.75% from the prior year.
  • Receivables - Other for Q1 2023 stood at $95.0 million, down from $102.0 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $102.0 million in Q4 2022 and bottomed at $32.0 million in Q4 2021.
  • The 3-year median for Receivables - Other is $81.5 million (2022), against an average of $78.3 million.
  • The widest annual swing landed in 2022, when Receivables - Other jumped 218.75%; it then advanced 17.28% in 2023.
  • A 3-year view of Receivables - Other shows it stood at $32.0 million in 2021, then surged by 218.75% to $102.0 million in 2022, then retreated by 6.86% to $95.0 million in 2023.
  • The last three Receivables - Other figures came in at $95.0 million (Q1 2023), $102.0 million (Q4 2022), and $82.0 million (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Bausch & Lomb 5.74 Bn 5.53 Bn 973.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2023 95.00 Mn
Mar 31, 2023 95.00 Mn
Dec 31, 2022 102.00 Mn
Dec 31, 2022 102.00 Mn
Sep 30, 2022 82.00 Mn
Sep 30, 2022 82.00 Mn
Jun 30, 2022 78.00 Mn
Jun 30, 2022 78.00 Mn
Mar 31, 2022 81.00 Mn
Mar 31, 2022 81.00 Mn
Dec 31, 2021 32.00 Mn
Dec 31, 2021 32.00 Mn